Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$656M Buy
2,459,446
+134,273
+6% +$37.2M 0.14% 132
2025
Q4
$640M Buy
2,325,173
+23,202
+1% +$6.5M 0.14% 132
2025
Q3
$664M Sell
2,301,971
-576,622
-20% -$171M 0.14% 122
2025
Q2
$952M Buy
2,878,593
+411,687
+17% +$133M 0.19% 106
2025
Q1
$812M Sell
2,466,906
-28,686
-1% -$8.64M 0.21% 100
2024
Q4
$689M Buy
2,495,592
+326,633
+15% +$104M 0.16% 118
2024
Q3
$751M Buy
2,168,959
+44,810
+2% +$15.4M 0.19% 96
2024
Q2
$702M Buy
2,124,149
+565,472
+36% +$195M 0.2% 89
2024
Q1
$566M Sell
1,558,677
-97,230
-6% -$32M 0.2% 89
2023
Q4
$496M Sell
1,655,907
-370,854
-18% -$108M 0.2% 100
2023
Q3
$580M Buy
2,026,761
+109,533
+6% +$31.2M 0.26% 74
2023
Q2
$490M Hold
1,917,228
0.24% 87
2023
Q1
$490M Buy
1,917,228
+139,895
+8% +$40.8M 0.24% 87
2022
Q4
$589M Buy
1,777,333
+165,995
+10% +$52.5M 0.31% 69
2022
Q3
$447M Buy
1,611,338
+99,144
+7% +$27.9M 0.25% 83
2022
Q2
$398M Sell
1,512,194
-128,384
-8% -$33.1M 0.21% 95
2022
Q1
$393M Sell
1,640,578
-232,772
-12% -$54.5M 0.17% 123
2021
Q4
$430M Buy
1,873,350
+307,265
+20% +$65.3M 0.16% 129
2021
Q3
$313M Buy
1,566,085
+12,534
+0.8% +$2.73M 0.13% 165
2021
Q2
$368M Sell
1,553,551
-65,560
-4% -$16.4M 0.16% 140
2021
Q1
$391M Buy
1,619,111
+86,528
+6% +$19.3M 0.17% 119
2020
Q4
$319M Sell
1,532,583
-168,770
-10% -$33.1M 0.15% 136
2020
Q3
$288M Buy
1,701,353
+83,639
+5% +$14.7M 0.15% 125
2020
Q2
$304M Buy
1,617,714
+3,347
+0.2% +$635K 0.19% 113
2020
Q1
$286M Buy
1,614,367
+146,570
+10% +$28.4M 0.21% 93
2019
Q4
$300M Buy
1,467,797
+40,369
+3% +$7.4M 0.18% 105
2019
Q3
$217M Sell
1,427,428
-89,151
-6% -$14.5M 0.15% 149
2019
Q2
$239M Sell
1,516,579
-289,141
-16% -$45.3M 0.17% 117
2019
Q1
$290M Sell
1,805,720
-302,228
-14% -$55.2M 0.22% 91
2018
Q4
$400M Buy
2,107,948
+499,851
+31% +$104M 0.35% 57
2018
Q3
$335M Buy
1,608,097
+187,591
+13% +$34.8M 0.25% 81
2018
Q2
$241M Sell
1,420,506
-18,007
-1% -$3.12M 0.19% 112
2018
Q1
$241M Sell
1,438,513
-248,138
-15% -$48.2M 0.19% 113
2017
Q4
$343M Buy
1,686,651
+168,740
+11% +$33.6M 0.29% 68
2017
Q3
$284M Buy
1,517,911
+69,877
+5% +$12.4M 0.26% 81
2017
Q2
$242M Buy
1,448,034
+38,512
+3% +$6.19M 0.23% 91
2017
Q1
$206M Buy
1,409,522
+103,773
+8% +$15.3M 0.21% 107
2016
Q4
$174M Buy
1,305,749
+573,696
+78% +$75.1M 0.2% 118
2016
Q3
$95.4M Sell
732,053
-340,883
-32% -$44.5M 0.1% 227
2016
Q2
$137M Sell
1,072,936
-498
-0% -$65.7K 0.16% 154
2016
Q1
$147M Buy
1,073,434
+61,211
+6% +$8.41M 0.17% 136
2015
Q4
$148M Sell
1,012,223
-352,774
-26% -$48.5M 0.17% 141
2015
Q3
$184M Buy
1,364,997
+377,978
+38% +$54.9M 0.2% 109
2015
Q2
$160M Sell
987,019
-173,288
-15% -$23.9M 0.15% 145
2015
Q1
$150M Sell
1,160,307
-58,022
-5% -$6.74M 0.14% 163
2014
Q4
$125M Sell
1,218,329
-31,636
-3% -$3.12M 0.12% 198
2014
Q3
$113M Buy
1,249,965
+184,086
+17% +$17.2M 0.11% 195
2014
Q2
$98M Buy
1,065,879
+136,410
+15% +$11.7M 0.1% 243
2014
Q1
$77.8M Buy
929,469
+55,889
+6% +$4.6M 0.08% 270
2013
Q4
$76.4M Sell
873,580
-85,146
-9% -$6.97M 0.09% 257
2013
Q3
$73.7M Buy
958,726
+10,446
+1% +$816K 0.09% 247
2013
Q2
$68.7M Buy
+948,280
New +$63.9M 0.09% 252

Other funds holding CI

UBS AM's CI Position: Q1 2026 in Review

UBS AM increased its Cigna (CI) stake by 5.8% in Q1 2026, buying an estimated $37.2M and bringing the position to 2,459,446 shares worth $656M. The position accounts for 0.14% of the portfolio, ranked #132.

UBS AM first reported a position in CI in Q2 2013 and has held it in 52 quarters since. The position peaked at $952M in Q2 2025. 1,654 funds tracked by Wall St. Rank hold CI as of Q1 2026.

  • UBS AM held 2,459,446 shares of Cigna worth $656M as of Q1 2026.
  • UBS AM bought 134,273 Cigna shares in Q1 2026, an estimated $37.2M.
  • Cigna made up 0.14% of UBS AM's portfolio in Q1 2026, its #132 holding.
  • UBS AM first reported a position in Cigna in Q2 2013 and has held it in 52 quarters since.
  • UBS AM's Cigna position peaked at $952M in Q2 2025.
  • 1,654 funds tracked by Wall St. Rank held Cigna as of Q1 2026.

Based on UBS AM's 13F filing for Q1 2026, filed 13 May 2026.